Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors.

Autor: Fitton I (AUTHOR), Steenbakkers RJ (AUTHOR), Gilhuijs K (AUTHOR), Duppen JC (AUTHOR), Nowak PJ (AUTHOR), van Herk M (AUTHOR), Rasch CR (AUTHOR), Fitton, Isabelle¹ (AUTHOR), Steenbakkers, Roel J H M (AUTHOR), Gilhuijs, Kenneth (AUTHOR), Duppen, Joop C (AUTHOR), Nowak, Peter J C M (AUTHOR), van Herk, Marcel (AUTHOR), Rasch, Coen R N (AUTHOR)

Publikováno v: International Journal of Radiation Oncology, Biology, Physics. Apr2008, Vol. 70 Issue 5, p1403-1407. 5p.

Impact of coronal and sagittal views on lung gross tumor volume delineation.

Autor: Fitton I; Georges Pompidou European Hospital, Paris, France., Duppen JC; The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Steenbakkers RJ; University Medical Center Groningen, Groningen, The Netherlands., Lotz H; University Medical Center Groningen, Groningen, The Netherlands., Nowak PJ; ERASMUS University Medical Center, Rotterdam, The Netherlands., Rasch CR; Academic Medical Center, Amsterdam, The Netherlands., van Herk M; University of Manchester, c/o Christie Hospital NHS Foundation Trust, Manchester, United Kingdom. Electronic address: marcel.vanherk@manchester.ac.uk.

Publikováno v: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2016 Sep; Vol. 32 (9), pp. 1082-7. Date of Electronic Publication: 2016 Sep 03.

Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.

Autor: van Dijk LV; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Institute for Biomedical Technology and Technical Medicine (MIRA), University of Twente, Enschede, The Netherlands., Steenbakkers RJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., ten Haken B; Institute for Biomedical Technology and Technical Medicine (MIRA), University of Twente, Enschede, The Netherlands., van der Laan HP; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van 't Veld AA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Korevaar EW; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: PloS one [PLoS One] 2016 Mar 31; Vol. 11 (3), pp. e0152477. Date of Electronic Publication: 2016 Mar 31 (Print Publication: 2016).

Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.

Autor: Bruine de Bruin L; Department of Otolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, The Netherlands; Graduate School of Medical Sciences (Damage and Repair in Cancer Development and Cancer Treatment), University of Groningen, The Netherlands., Bollineni VR; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands and Department of Nuclear Medicine, Tygerberg Hospital, Stellenbosch University, South Africa., Wachters JE; Department of Otolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, The Netherlands; Graduate School of Medical Sciences (Damage and Repair in Cancer Development and Cancer Treatment), University of Groningen, The Netherlands., Schuuring E; Department of Pathology, University of Groningen, University Medical Center Groningen, The Netherlands., van Hemel BM; Department of Pathology, University of Groningen, University Medical Center Groningen, The Netherlands., van der Wal JE; Department of Pathology, University of Groningen, University Medical Center Groningen, The Netherlands; Department of Pathology, Martini Hospital Groningen, The Netherlands., Slagter-Menkema L; Department of Pathology, University of Groningen, University Medical Center Groningen, The Netherlands., de Bock GH; Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands., Steenbakkers RJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Pruim J; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands and Department of Nuclear Medicine, Tygerberg Hospital, Stellenbosch University, South Africa., van der Laan BF; Department of Otolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, The Netherlands., Halmos GB; Department of Otolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: g.b.halmos@umcg.nl.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Oct; Vol. 117 (1), pp. 106-12. Date of Electronic Publication: 2015 Aug 03.

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

Autor: Brouwer CL; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands., Steenbakkers RJ; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands., Bourhis J; Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland(2)., Budach W; Department of Radiation Oncology, University Hospital Düsseldorf, Germany., Grau C; Department of Oncology, Aarhus University Hospital, Denmark(3)., Grégoire V; Cancer Center and Department of Radiation Oncology, Clinical and Experimental Research Institute, Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium(4)., van Herk M; Christie Hospital and University of Manchester, Manchester, UK., Lee A; Department of Clinical Oncology, The University of Hong Kong (Shenzhen) Hospital, China(5)., Maingon P; Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon, France(6)., Nutting C; Department of Radiation Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK(7)., O'Sullivan B; Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Canada(8)., Porceddu SV; Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia(9)., Rosenthal DI; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston TX, USA(10)., Sijtsema NM; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands., Langendijk JA; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Oct; Vol. 117 (1), pp. 83-90. Date of Electronic Publication: 2015 Aug 13.